| Literature DB >> 35289515 |
Filipe Brasil E Silva1, Mario Vaisman2, Thalita Ponce2,3, Thiago Ramos de Barros3,4, Camila Brasil E Silva5, Verônica Pinto Salerno3, Míriam Raquel Meira Mainenti6.
Abstract
The fundamental objective of military field training exercises (FTX) is to prepare military personnel for real-life operations through simulated scenarios. These training sessions often require extreme physical efforts with prolonged, high-intensity exercises that can be combined with food restrictions and partial, or total, sleep deprivation. Such conditions can compromise an individual's physical performance and cause tissue damage, thus affecting their health. This study aimed to perform a systematic review of the literature to identify studies that measured the changes in hormone levels and biomarkers of cellular injury and oxidative stress resulting from FTX with high levels of energy expenditure combined with food and sleep restrictions. PubMed and the Scopus database were searched for articles that combined physical effort/food restriction/sleep deprivation with military training. The initial database search identified 158 articles that were reduced to 18 after confirmation. Significant reductions were reported in thyroid hormones, T3, T4, and anabolic hormones such as testosterone, insulin and androstenedione. An exception for GH was found, which increased throughout FTX. Less distinct responses to FTX were observed with cortisol, TSH and LH. The presence of biomarkers for cellular damage (myoglobin, TNF, and CRP) and increased immune response activities were also described. The scarcity of information on oxidative stress, analyses of cellular injury and biomarkers of inflammatory responses warrants the future study of these topics, which could be helpful in facilitating the safe and effective physical preparations of the members of the armed forces.Entities:
Keywords: Military training; endocrinology; food deprivation; oxidative damage; physical effort
Year: 2022 PMID: 35289515 DOI: 10.20945/2359-3997000000443
Source DB: PubMed Journal: Arch Endocrinol Metab ISSN: 2359-3997 Impact factor: 2.309